3 Top Diabetes Stocks to Watch in August
Drugs and medical devices indicated for the treatment of diabetes are a booming part of the diverse healthcare sector. Over the next decade, in fact, diabetes products are projected to be the second fastest-growing area of the entire sector, according to a recent industry report by EvaluatePharma.
Armed with this insight, we asked three of our Motley Fool healthcare contributors which diabetes stocks they think should be on every investor's radar during the month of August and beyond. They picked Eli Lilly (NYSE: LLY), Abbott Laboratories (NYSE: ABT), and Tandem Diabetes Care (NASDAQ: TNDM). Here's why.
Image source: Getty Images.
Source Fool.com
